Shearman & Sterling advised CVS Health Corporation and Simpson Thacher & Bartlett LLP advised the underwriters. CVS Health Corporation, a leading diversified health solutions company, has announced...
CVS Health’s $5 Billion Debt Offering
BD’s $1.525 Billion Acquisition of Parata Systems
Goodwin Procter advised Frazier Healthcare Partners on the deal. Frazier Healthcare Partners announced its definitive agreement with BD (Becton, Dickinson and Company) (NYSE: BDX) for BD to...
Frazier Healthcare Partners’ Acquisition of Apollo Intelligence
Goodwin Procter advised Apollo Intelligence on the deal. Apollo Intelligence announced its sale to Frazier Healthcare Partners. Apollo will continue to focus on elevating industry standards for...
Sichuan Kelun-Biotech Biopharmaceutical’s License Agreement with Merck
Goodwin Procter advised Sichuan Kelun-Biotech Biopharmaceutical Co. on the deal. Sichuan Kelun-Biotech Biopharmaceutical Co. announced its exclusive license and collaboration agreement with Merck for ex-China development...
PointClickCare Technologies’ Acquisition of Audacious Inquiry
Goodwin Procter advised Audacious Inquiry on the deal. Audacious Inquiry announced its agreement to be acquired by PointClickCare Technologies. Audacious Inquiry is a national industry-shaping health IT...
Doximity’s $605.8 Million IPO
Goodwin Procter LLP advised Doximity on the deal. Doximity (NYSE: DOCS) announced its initial public offering of 23,300,000 shares of its Class A common stock at a...